26 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation … and the registrar for the Ordinary Shares or the ADSs (x) the filing and other fees incident to any review by FINRA of the terms of the sale
424B3
zi48jarn3k
29 Apr 21
Prospectus supplement
6:10am
S-3
2b2mr
15 Apr 21
Shelf registration
4:03pm
8-K
EX-10.1
sr19lt1
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
S-4
EX-10.7
77l41a
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-2.1
06v zm17baeymyh
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.6
wnow28giq wcgu4f
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
eucxw
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
4kv19f814qq0q7
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-1.1
zd65lywk6arixyc466i1
14 Feb 19
Current report (foreign)
4:40pm
424B4
cokm 9wlipytqq45y7
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
anhjqcdmh19c y752
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
ke7sf b77f1ybc2bh
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
94oq314ql2dy26l
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
cwrq5lt8hwmh1p
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.5
ry7nlj5jvgc1s
7 Jan 19
Registration statement (foreign)
5:11pm